NCT06818201 Effects of tDCS on Motor Cortex During ACL Recovery
| NCT ID | NCT06818201 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundación Universidad Católica de Valencia San Vicente Mártir |
| Condition | Anterior Cruciate Ligament Reconstruction Rehabilitation |
| Study Type | INTERVENTIONAL |
| Enrollment | 54 participants |
| Start Date | 2025-11-28 |
| Primary Completion | 2027-12-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 54 participants in total. It began in 2025-11-28 with a primary completion date of 2027-12-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Anterior Cruciate Ligament (ACL) is a prevalent injury, particularly among young and physically active individuals. The efficacy of transcranial direct current stimulation (tDCS) and exercise-based rehabilitation on neuromuscular control in post-ACL reconstruction patients is evaluated, and these techniques are combined.
Eligibility Criteria
Inclusion Criteria: * Diagnosis complete ACL tear through clinical evaluation and MRI imaging. * Patients who have received surgical intervention. * Aged between 16 and 40 years. * Tegner activity level of 4 or higher. Exclusion Criteria: * Rupture, such as tendons, cartilage, bones, or ligaments. * Absence of any pre-existing or current lower limb pathologies, such as open surgeries, knee arthroscopies, or femur/tibia fractures. * Neuromuscular or metabolic diseases. * Concussion within the past six months are not eligible. * Cranial surgery or have intracranial metal clips are ineligible. * Taking medications that affect neuronal activity. * Neurological diseases or disorders are not eligible for participation.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06818201 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 40 Years, studying Anterior Cruciate Ligament Reconstruction Rehabilitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06818201 currently recruiting?
Yes, NCT06818201 is actively recruiting participants. Contact the research team at juan.vicente@ucv.es for enrollment information.
Where is the NCT06818201 trial being conducted?
This trial is being conducted at Valencia, Spain.
Who is sponsoring the NCT06818201 clinical trial?
NCT06818201 is sponsored by Fundación Universidad Católica de Valencia San Vicente Mártir. The trial plans to enroll 54 participants.